4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001181431-11-051848
CIK 0001484478operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:03 PM ET
Size
8.9 KB
Accession
0001181431-11-051848
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Award
Stock Options (to buy)
2011-10-03+37,944→ 37,944 totalExercise: $13.16Exp: 2021-10-03→ Common Stock (37,944 underlying)
Holdings
- 75,691
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (75,691 underlying) - 73
Common Stock
- 26,000
Stock Options (to buy)
Exercise: $15.00Exp: 2021-05-09→ Common Stock (26,000 underlying)
Footnotes (3)
- [F1]The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F2]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
- [F3]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:03 PM ET
- Size
- 8.9 KB